Global Hospital-Acquired Infection Control Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Hospital-Acquired Infection Control Revenue
• 1.4 Market by Type
  • 1.4.1 Global Hospital-Acquired Infection Control Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Catheter-associated Urinary Tract Infections (CAUTIs)
  • 1.4.3 Surgical Site Infections (SSIs)
  • 1.4.4 Central Line-associated Bloodstream Infections (CLABSIs)
  • 1.4.5 Respiratory Infections
• 1.5 Market by Application
  • 1.5.1 Global Hospital-Acquired Infection Control Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospitals and ICUs
  • 1.5.3 Outpatient Care Centers
  • 1.5.4 Long-term Care Facilities (LTCFs)
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Hospital-Acquired Infection Control Market Perspective (2015-2026)
• 2.2 Global Hospital-Acquired Infection Control Growth Trends by Regions
  • 2.2.1 Hospital-Acquired Infection Control Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Hospital-Acquired Infection Control Historic Market Share by Regions (2015-2020)
  • 2.2.3 Hospital-Acquired Infection Control Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Hospital-Acquired Infection Control Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Hospital-Acquired Infection Control Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Hospital-Acquired Infection Control Players by Market Size
  • 3.1.1 Global Top Hospital-Acquired Infection Control Players by Revenue (2015-2020)
  • 3.1.2 Global Hospital-Acquired Infection Control Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Hospital-Acquired Infection Control Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Hospital-Acquired Infection Control Market Concentration Ratio
  • 3.2.1 Global Hospital-Acquired Infection Control Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Hospital-Acquired Infection Control Revenue in 2019
• 3.3 Hospital-Acquired Infection Control Key Players Head office and Area Served
• 3.4 Key Players Hospital-Acquired Infection Control Product Solution and Service
• 3.5 Date of Enter into Hospital-Acquired Infection Control Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Hospital-Acquired Infection Control Historic Market Size by Type (2015-2020)
• 4.2 Global Hospital-Acquired Infection Control Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Hospital-Acquired Infection Control Market Size by Application (2015-2020)
• 5.2 Global Hospital-Acquired Infection Control Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Hospital-Acquired Infection Control Market Size (2015-2020)
• 6.2 Hospital-Acquired Infection Control Key Players in North America (2019-2020)
• 6.3 North America Hospital-Acquired Infection Control Market Size by Type (2015-2020)
• 6.4 North America Hospital-Acquired Infection Control Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Hospital-Acquired Infection Control Market Size (2015-2020)
• 7.2 Hospital-Acquired Infection Control Key Players in Europe (2019-2020)
• 7.3 Europe Hospital-Acquired Infection Control Market Size by Type (2015-2020)
• 7.4 Europe Hospital-Acquired Infection Control Market Size by Application (2015-2020)

8 China

• 8.1 China Hospital-Acquired Infection Control Market Size (2015-2020)
• 8.2 Hospital-Acquired Infection Control Key Players in China (2019-2020)
• 8.3 China Hospital-Acquired Infection Control Market Size by Type (2015-2020)
• 8.4 China Hospital-Acquired Infection Control Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Hospital-Acquired Infection Control Market Size (2015-2020)
• 9.2 Hospital-Acquired Infection Control Key Players in Japan (2019-2020)
• 9.3 Japan Hospital-Acquired Infection Control Market Size by Type (2015-2020)
• 9.4 Japan Hospital-Acquired Infection Control Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Hospital-Acquired Infection Control Market Size (2015-2020)
• 10.2 Hospital-Acquired Infection Control Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Hospital-Acquired Infection Control Market Size by Type (2015-2020)
• 10.4 Southeast Asia Hospital-Acquired Infection Control Market Size by Application (2015-2020)

11 India

• 11.1 India Hospital-Acquired Infection Control Market Size (2015-2020)
• 11.2 Hospital-Acquired Infection Control Key Players in India (2019-2020)
• 11.3 India Hospital-Acquired Infection Control Market Size by Type (2015-2020)
• 11.4 India Hospital-Acquired Infection Control Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Hospital-Acquired Infection Control Market Size (2015-2020)
• 12.2 Hospital-Acquired Infection Control Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Hospital-Acquired Infection Control Market Size by Type (2015-2020)
• 12.4 Central & South America Hospital-Acquired Infection Control Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 GSK
  • 13.1.1 GSK Company Details
  • 13.1.2 GSK Business Overview
  • 13.1.3 GSK Hospital-Acquired Infection Control Introduction
  • 13.1.4 GSK Revenue in Hospital-Acquired Infection Control Business (2015-2020))
  • 13.1.5 GSK Recent Development
• 13.2 Merck
  • 13.2.1 Merck Company Details
  • 13.2.2 Merck Business Overview
  • 13.2.3 Merck Hospital-Acquired Infection Control Introduction
  • 13.2.4 Merck Revenue in Hospital-Acquired Infection Control Business (2015-2020)
  • 13.2.5 Merck Recent Development
• 13.3 Pfizer
  • 13.3.1 Pfizer Company Details
  • 13.3.2 Pfizer Business Overview
  • 13.3.3 Pfizer Hospital-Acquired Infection Control Introduction
  • 13.3.4 Pfizer Revenue in Hospital-Acquired Infection Control Business (2015-2020)
  • 13.3.5 Pfizer Recent Development
• 13.4 3M
  • 13.4.1 3M Company Details
  • 13.4.2 3M Business Overview
  • 13.4.3 3M Hospital-Acquired Infection Control Introduction
  • 13.4.4 3M Revenue in Hospital-Acquired Infection Control Business (2015-2020)
  • 13.4.5 3M Recent Development
• 13.5 Abbott
  • 13.5.1 Abbott Company Details
  • 13.5.2 Abbott Business Overview
  • 13.5.3 Abbott Hospital-Acquired Infection Control Introduction
  • 13.5.4 Abbott Revenue in Hospital-Acquired Infection Control Business (2015-2020)
  • 13.5.5 Abbott Recent Development
• 13.6 BD
  • 13.6.1 BD Company Details
  • 13.6.2 BD Business Overview
  • 13.6.3 BD Hospital-Acquired Infection Control Introduction
  • 13.6.4 BD Revenue in Hospital-Acquired Infection Control Business (2015-2020)
  • 13.6.5 BD Recent Development
• 13.7 Cepheid
  • 13.7.1 Cepheid Company Details
  • 13.7.2 Cepheid Business Overview
  • 13.7.3 Cepheid Hospital-Acquired Infection Control Introduction
  • 13.7.4 Cepheid Revenue in Hospital-Acquired Infection Control Business (2015-2020)
  • 13.7.5 Cepheid Recent Development
• 13.8 Getinge Group
  • 13.8.1 Getinge Group Company Details
  • 13.8.2 Getinge Group Business Overview
  • 13.8.3 Getinge Group Hospital-Acquired Infection Control Introduction
  • 13.8.4 Getinge Group Revenue in Hospital-Acquired Infection Control Business (2015-2020)
  • 13.8.5 Getinge Group Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer